Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (DRKS00041093) titled 'Stereotactic and Palliative Radiotherapy for Metastatic Ovarian Cancer: Analysis of Treatment Response and Clinical Outcomes' on Sept. 7.
Study Type: observational
Study Design:
Allocation:
Masking:
Control:
Assignment:
Study design purpose: health services research
Primary Sponsor: Uniklinikum Dusseldorf
Condition:
C56
C57
C48
Malignant neoplasm of ovary
Malignant neoplasm of other and unspecified female genital organs
Malignant neoplasm of retroperitoneum and peritoneum
Intervention:
Group 1: Patients with metastatic or oligoprogressive ovarian cancer who have received stereotactic or palliative radiother...